115 related articles for article (PubMed ID: 25169055)
21. Expression of pigment epithelial derived factor is reduced in non-small cell lung cancer and is linked to clinical outcome.
Zhang L; Chen J; Ke Y; Mansel RE; Jiang WG
Int J Mol Med; 2006 May; 17(5):937-44. PubMed ID: 16596284
[TBL] [Abstract][Full Text] [Related]
22. Differential expression and distribution of epithelial adhesion molecules in non-small cell lung cancer and normal bronchus.
Boelens MC; van den Berg A; Vogelzang I; Wesseling J; Postma DS; Timens W; Groen HJ
J Clin Pathol; 2007 Jun; 60(6):608-14. PubMed ID: 16489176
[TBL] [Abstract][Full Text] [Related]
23. Biomarker discovery in non-small cell lung cancer: integrating gene expression profiling, meta-analysis, and tissue microarray validation.
Botling J; Edlund K; Lohr M; Hellwig B; Holmberg L; Lambe M; Berglund A; Ekman S; Bergqvist M; Pontén F; König A; Fernandes O; Karlsson M; Helenius G; Karlsson C; Rahnenführer J; Hengstler JG; Micke P
Clin Cancer Res; 2013 Jan; 19(1):194-204. PubMed ID: 23032747
[TBL] [Abstract][Full Text] [Related]
24. Ornithine decarboxylase mRNA expression in curatively resected non-small-cell lung cancer.
Grimminger PP; Schneider PM; Metzger R; Vallböhmer D; Danenberg KD; Danenberg PV; Hölscher AH; Brabender J
Clin Lung Cancer; 2010 Mar; 11(2):114-9. PubMed ID: 20199977
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of CD88 predicts poor prognosis in non-small-cell lung cancer.
Gu J; Ding JY; Lu CL; Lin ZW; Chu YW; Zhao GY; Guo J; Ge D
Lung Cancer; 2013 Aug; 81(2):259-65. PubMed ID: 23706417
[TBL] [Abstract][Full Text] [Related]
26. 5' CpG island methylation of the FHIT gene is correlated with loss of gene expression in lung and breast cancer.
Zöchbauer-Müller S; Fong KM; Maitra A; Lam S; Geradts J; Ashfaq R; Virmani AK; Milchgrub S; Gazdar AF; Minna JD
Cancer Res; 2001 May; 61(9):3581-5. PubMed ID: 11325823
[TBL] [Abstract][Full Text] [Related]
27. Up-regulation of survivin mRNA might be a marker for non-invasive detection of non-small cell lung cancer rather than for prognosis.
Warnecke-Eberz U; Baldus SE; Bollschweiler E; Hoelscher AH; Metzger R
Anticancer Res; 2008; 28(3A):1525-9. PubMed ID: 18630507
[TBL] [Abstract][Full Text] [Related]
28. The RHOV gene is overexpressed in human non-small cell lung cancer.
Shepelev MV; Korobko IV
Cancer Genet; 2013 Nov; 206(11):393-7. PubMed ID: 24388711
[TBL] [Abstract][Full Text] [Related]
29. Protein expression in human non-small cell lung cancer: a systematic database.
Bührens RI; Amelung JT; Reymond MA; Beshay M
Pathobiology; 2009; 76(6):277-85. PubMed ID: 19955839
[TBL] [Abstract][Full Text] [Related]
30. Mesenchymal stem cells in non-small cell lung cancer--different from others? Insights from comparative molecular and functional analyses.
Gottschling S; Granzow M; Kuner R; Jauch A; Herpel E; Xu EC; Muley T; Schnabel PA; Herth FJ; Meister M
Lung Cancer; 2013 Apr; 80(1):19-29. PubMed ID: 23294501
[TBL] [Abstract][Full Text] [Related]
31. Genome-wide combination profiling of DNA copy number and methylation for deciphering biomarkers in non-small cell lung cancer patients.
Son JW; Jeong KJ; Jean WS; Park SY; Jheon S; Cho HM; Park CG; Lee HY; Kang J
Cancer Lett; 2011 Dec; 311(1):29-37. PubMed ID: 21757291
[TBL] [Abstract][Full Text] [Related]
32. Identification of genes (SPON2 and C20orf2) differentially expressed between cancerous and noncancerous lung cells by mRNA differential display.
Manda R; Kohno T; Matsuno Y; Takenoshita S; Kuwano H; Yokota J
Genomics; 1999 Oct; 61(1):5-14. PubMed ID: 10512675
[TBL] [Abstract][Full Text] [Related]
33. Characterization of a cleavage stimulation factor, 3' pre-RNA, subunit 2, 64 kDa (CSTF2) as a therapeutic target for lung cancer.
Aragaki M; Takahashi K; Akiyama H; Tsuchiya E; Kondo S; Nakamura Y; Daigo Y
Clin Cancer Res; 2011 Sep; 17(18):5889-900. PubMed ID: 21813631
[TBL] [Abstract][Full Text] [Related]
34. High TBX2 expression predicts poor prognosis in non-small cell lung cancer.
Zhang Z; Guo Y
Neoplasma; 2014; 61(4):476-80. PubMed ID: 25027744
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of immunohistochemical markers in non-small cell lung cancer by unsupervised hierarchical clustering analysis: a tissue microarray study of 284 cases and 18 markers.
Au NH; Cheang M; Huntsman DG; Yorida E; Coldman A; Elliott WM; Bebb G; Flint J; English J; Gilks CB; Grimes HL
J Pathol; 2004 Sep; 204(1):101-9. PubMed ID: 15307143
[TBL] [Abstract][Full Text] [Related]
36. Loss of FHIT function in lung cancer and preinvasive bronchial lesions.
Sozzi G; Pastorino U; Moiraghi L; Tagliabue E; Pezzella F; Ghirelli C; Tornielli S; Sard L; Huebner K; Pierotti MA; Croce CM; Pilotti S
Cancer Res; 1998 Nov; 58(22):5032-7. PubMed ID: 9823304
[TBL] [Abstract][Full Text] [Related]
37. Altered retinoblastoma protein expression in nonsmall cell lung cancer: its synergistic effects with altered ras and p53 protein status on prognosis.
Dosaka-Akita H; Hu SX; Fujino M; Harada M; Kinoshita I; Xu HJ; Kuzumaki N; Kawakami Y; Benedict WF
Cancer; 1997 Apr; 79(7):1329-37. PubMed ID: 9083154
[TBL] [Abstract][Full Text] [Related]
38. Association between clinical pathology and multiple genes mRNA expression in Chinese patients with NSCLC.
Chen G; Jundong GU; Chen J; Liu Y; Song Z
J Cancer Res Ther; 2013 Sep; 9 Suppl 2():S98-100. PubMed ID: 24135250
[TBL] [Abstract][Full Text] [Related]
39. Defining the human gallbladder proteome by transcriptomics and affinity proteomics.
Kampf C; Mardinoglu A; Fagerberg L; Hallström BM; Danielsson A; Nielsen J; Pontén F; Uhlen M
Proteomics; 2014 Nov; 14(21-22):2498-507. PubMed ID: 25175928
[TBL] [Abstract][Full Text] [Related]
40. The Human Adrenal Gland Proteome Defined by Transcriptomics and Antibody-Based Profiling.
Bergman J; Botling J; Fagerberg L; Hallström BM; Djureinovic D; Uhlén M; Pontén F
Endocrinology; 2017 Feb; 158(2):239-251. PubMed ID: 27901589
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
